A Patient Who Is at Risk for Osteoporosis Will Begin

A patient who is at risk for osteoporosis will begin taking the selective estrogen receptor modulator raloxifene [Evista]. Which statement will the nurse include when teaching this patient about the medication?

A) Raloxifene reduces the risk of thromboembolism.
B) The drug is associated with an increased risk of breast cancer.
C) Use of this drug increases the risk of endometrial carcinoma.
D) Vasomotor symptoms are a common side effect of this drug.

Correct Answer:

Verified

Unlock this answer now
Get Access to more Verified Answers free of charge

Access For Free